Title : Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo.

Pub. Date : 2017 May

PMID : 28282575






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Together, these findings suggest that GM-CSF-secreting cellular immunotherapy may be integrated with sorafenib without impairing vaccine-based immune responses. Sorafenib colony stimulating factor 2 (granulocyte-macrophage) Mus musculus